Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Dow
Healthtrust
Express Scripts
Merck
Harvard Business School
Cerilliant
Johnson and Johnson

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088260

« Back to Dashboard

NDA 088260 describes FLUOXYMESTERONE, which is a drug marketed by Usl Pharma, Valeant Pharm Intl, and Watson Labs, and is included in five NDAs. It is available from one supplier. Additional details are available on the FLUOXYMESTERONE profile page.

The generic ingredient in FLUOXYMESTERONE is fluoxymesterone. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fluoxymesterone profile page.
Summary for 088260
Tradename:FLUOXYMESTERONE
Applicant:Watson Labs
Ingredient:fluoxymesterone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 088260

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Dec 6, 1983TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Deloitte
Covington
Teva
Federal Trade Commission
Julphar
McKesson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.